Original Source(s)
Related Content
FDA Expands CAPVAXIVE Pediatric Use
Phase 3 data showed noninferior immune responses vs pneumococcal 23-valent polysaccharide vaccine in pediatric patients at increased risk.
June 18, 2026
-
2 min
When Bad Data Enters the Drug Pipeline
Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.
June 11, 2026
-
2 min
Sleep Program Shifted Teen Circadian Timing
Two-week chronotherapy trial evaluates circadian phase, sleep duration, and alignment outcomes.
May 13, 2026
-
6 min